During initial treatment, GLP-1 medications produce more pronounced gastric emptying delay
However, no associations between choline or betaine intakes and cardiovascular-related mortality were found in a cohort study of Japanese adults (n=29,079) (45)
Patients with Hashimoto's disease who have metabolic indications for GLP-1 therapy (type 2 diabetes or obesity) may benefit from these medications for those specific conditions, but should not expect direct thyroid benefits
f Plan data based on number of pharmacy lives as reported by Managed Markets Insight & Technology, LLC (current as of August 2023)
The decision to continue, modify, or cease treatment should be made collaboratively between patient and prescriber, weighing individual benefits against adverse effects whilst considering alternative weight management strategies
Phentermine acts as a sympathomimetic amine, increasing norepinephrine, serotonin, and dopamine levels in the brain's appetite control centers